Centers for Disease Control and Prevention. Kaposi’s Sarcoma and Pneumocystis cariniipneumonia among homosexual men—New York and California. MMWR. 1981; 30:305-308.
2.
Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-Lymphotrophic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science. 1983; 220: 868-871.
3.
Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987; 317:185-191.
4.
Pallela FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced Human Immunodeficiency Virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338:853-860.
5.
Department of Health and Human Services/Henry J Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in the HIV infected adults and adolescents. Rockville, MD: HIV/AIDS Treatment Information Service, January, 2000. (http://hivatis.org/trtgdlns.html).
6.
Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults—updated recommendations of the International AIDS Society—USA Panel. JAMA. 2000; 283:381-390.
7.
Hirsch M, Brun-Vezinet, F, D’Aquila Ret al. Antiretroviral drug resistance testing in adult HIV-1 infection. JAMA. 2000; 283:2417-2426.
8.
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with Human Immunodeficiency Virus. MMWR Morb Mortal Wkly Rep. 1999; 48:1-66.
